09.01.2013
  • Emmanuel PETIOT was formerly Director of Sales of NOVOZYMES in the United States.
  • Jacques BITON, CEO of DEINOVE since 2007, is appointed Chairman of the Scientific Advisory Board.


DEINOVE (Alternext Paris: Aldei) announces the appointment of Emmanuel PETIOT, formerly Director of Sales of NOVOZYMES North America, Inc. (the world leader in enzymes and microorganisms), as CEO of DEINOVE. Jacques BITON, CEO since 2007, is appointed Chairman of the Scientific Advisory Board of the company.

The primary goal of Emmanuel PETIOT will be to position the company internationally and to confirm its technological leadership by negotiating new agreements with corporate partners in the various markets targeted by DEINOVE. The company has now developed a powerful synthetic biology platform to optimize the natural enzymatic and metabolic properties of the Deinococcus bacteria. This highly innovative approach has attracted Emmanuel PETIOT, a senior executive in the field of enzymes and microorganisms. His extensive experience in biomass, biofuels and high value chemicals is a great asset for DEINOVE.